 | • レポートコード：QYR9ST04368 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、後天的孤児血液疾患治療薬の世界市場について調査・分析し、後天的孤児血液疾患治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（薬、骨髄移植、輸血、鉄療法）、用途別（病院、クリニック、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の後天的孤児血液疾患治療薬市場動向 ・主要企業別マーケットシェア ・後天的孤児血液疾患治療薬の種類別市場規模2014-2019 （薬、骨髄移植、輸血、鉄療法） ・後天的孤児血液疾患治療薬の用途別市場規模2014-2019 （病院、クリニック、その他） ・後天的孤児血液疾患治療薬の北米市場：主要企業・種類別/用途別市場規模 ・後天的孤児血液疾患治療薬のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・後天的孤児血液疾患治療薬の中国市場：主要企業・種類別/用途別市場規模 ・後天的孤児血液疾患治療薬の日本国内市場：主要企業・種類別/用途別市場規模 ・後天的孤児血液疾患治療薬の東南アジア市場：主要企業・種類別/用途別市場規模 ・後天的孤児血液疾患治療薬のインド市場：主要企業・種類別/用途別市場規模 ・後天的孤児血液疾患治療薬の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Alexion Pharmaceuticals、Amgen、Celgene Corporation、Eli Lilly、Sanofi、GlaxoSmithKline、Cyclacel Pharmaceuticals、Onconova Therapeutics、Incyte Corporation、CTI BioPharma） ・後天的孤児血液疾患治療薬の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Acquired orphan blood disease is a type of rare blood disorder, which occurs due to the presence of insufficient amount of red blood cells in the blood. This disease is characterized by the body’s inability to produce red blood cells. Moreover, improper functioning of bone marrow also leads to lack of red blood cells in blood, which in turn results in a decrease in platelet numbers. This decrease in platelet number causes anemia and thrombosis.Soliris (eculizumab) is a perfect example of a successful orphan blood disease drug. PNH is a potentially life-threatening blood disease, characterised by severe anemia caused by the destruction of red blood cells in the bloodstream. Bone marrow transplants can provide a cure, but the high risk procedure is suitable for only a few patients. Treatment methods include blood transfusions, iron therapy, and growth factors, but monoclonal antibody
In 2018, the global Acquired Orphan Blood Diseases Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Acquired Orphan Blood Diseases Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Acquired Orphan Blood Diseases Therapeutics development in United States, Europe and China.
The key players covered in this study
Alexion Pharmaceuticals
Amgen
Celgene Corporation
Eli Lilly
Sanofi
GlaxoSmithKline
Cyclacel Pharmaceuticals
Onconova Therapeutics
Incyte Corporation
CTI BioPharma
Market segment by Type, the product can be split into
Medication
Bone Marrow Transplant
Blood Transfusion
Iron Therapy
Market segment by Application, split into
Hospitals
Clinics
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Acquired Orphan Blood Diseases Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Acquired Orphan Blood Diseases Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Acquired Orphan Blood Diseases Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Acquired Orphan Blood Diseases Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Medication
1.4.3 Bone Marrow Transplant
1.4.4 Blood Transfusion
1.4.5 Iron Therapy
1.5 Market by Application
1.5.1 Global Acquired Orphan Blood Diseases Therapeutics Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Acquired Orphan Blood Diseases Therapeutics Market Size
2.2 Acquired Orphan Blood Diseases Therapeutics Growth Trends by Regions
2.2.1 Acquired Orphan Blood Diseases Therapeutics Market Size by Regions (2014-2025)
2.2.2 Acquired Orphan Blood Diseases Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Acquired Orphan Blood Diseases Therapeutics Market Size by Manufacturers
3.1.1 Global Acquired Orphan Blood Diseases Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Acquired Orphan Blood Diseases Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Acquired Orphan Blood Diseases Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Acquired Orphan Blood Diseases Therapeutics Key Players Head office and Area Served
3.3 Key Players Acquired Orphan Blood Diseases Therapeutics Product/Solution/Service
3.4 Date of Enter into Acquired Orphan Blood Diseases Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Acquired Orphan Blood Diseases Therapeutics Market Size by Type (2014-2019)
4.2 Global Acquired Orphan Blood Diseases Therapeutics Market Size by Application (2014-2019)
5 United States
5.1 United States Acquired Orphan Blood Diseases Therapeutics Market Size (2014-2019)
5.2 Acquired Orphan Blood Diseases Therapeutics Key Players in United States
5.3 United States Acquired Orphan Blood Diseases Therapeutics Market Size by Type
5.4 United States Acquired Orphan Blood Diseases Therapeutics Market Size by Application
6 Europe
6.1 Europe Acquired Orphan Blood Diseases Therapeutics Market Size (2014-2019)
6.2 Acquired Orphan Blood Diseases Therapeutics Key Players in Europe
6.3 Europe Acquired Orphan Blood Diseases Therapeutics Market Size by Type
6.4 Europe Acquired Orphan Blood Diseases Therapeutics Market Size by Application
7 China
7.1 China Acquired Orphan Blood Diseases Therapeutics Market Size (2014-2019)
7.2 Acquired Orphan Blood Diseases Therapeutics Key Players in China
7.3 China Acquired Orphan Blood Diseases Therapeutics Market Size by Type
7.4 China Acquired Orphan Blood Diseases Therapeutics Market Size by Application
8 Japan
8.1 Japan Acquired Orphan Blood Diseases Therapeutics Market Size (2014-2019)
8.2 Acquired Orphan Blood Diseases Therapeutics Key Players in Japan
8.3 Japan Acquired Orphan Blood Diseases Therapeutics Market Size by Type
8.4 Japan Acquired Orphan Blood Diseases Therapeutics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Acquired Orphan Blood Diseases Therapeutics Market Size (2014-2019)
9.2 Acquired Orphan Blood Diseases Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Acquired Orphan Blood Diseases Therapeutics Market Size by Type
9.4 Southeast Asia Acquired Orphan Blood Diseases Therapeutics Market Size by Application
10 India
10.1 India Acquired Orphan Blood Diseases Therapeutics Market Size (2014-2019)
10.2 Acquired Orphan Blood Diseases Therapeutics Key Players in India
10.3 India Acquired Orphan Blood Diseases Therapeutics Market Size by Type
10.4 India Acquired Orphan Blood Diseases Therapeutics Market Size by Application
11 Central & South America
11.1 Central & South America Acquired Orphan Blood Diseases Therapeutics Market Size (2014-2019)
11.2 Acquired Orphan Blood Diseases Therapeutics Key Players in Central & South America
11.3 Central & South America Acquired Orphan Blood Diseases Therapeutics Market Size by Type
11.4 Central & South America Acquired Orphan Blood Diseases Therapeutics Market Size by Application
12 International Players Profiles
12.1 Alexion Pharmaceuticals
12.1.1 Alexion Pharmaceuticals Company Details
12.1.2 Company Description and Business Overview
12.1.3 Acquired Orphan Blood Diseases Therapeutics Introduction
12.1.4 Alexion Pharmaceuticals Revenue in Acquired Orphan Blood Diseases Therapeutics Business (2014-2019)
12.1.5 Alexion Pharmaceuticals Recent Development
12.2 Amgen
12.2.1 Amgen Company Details
12.2.2 Company Description and Business Overview
12.2.3 Acquired Orphan Blood Diseases Therapeutics Introduction
12.2.4 Amgen Revenue in Acquired Orphan Blood Diseases Therapeutics Business (2014-2019)
12.2.5 Amgen Recent Development
12.3 Celgene Corporation
12.3.1 Celgene Corporation Company Details
12.3.2 Company Description and Business Overview
12.3.3 Acquired Orphan Blood Diseases Therapeutics Introduction
12.3.4 Celgene Corporation Revenue in Acquired Orphan Blood Diseases Therapeutics Business (2014-2019)
12.3.5 Celgene Corporation Recent Development
12.4 Eli Lilly
12.4.1 Eli Lilly Company Details
12.4.2 Company Description and Business Overview
12.4.3 Acquired Orphan Blood Diseases Therapeutics Introduction
12.4.4 Eli Lilly Revenue in Acquired Orphan Blood Diseases Therapeutics Business (2014-2019)
12.4.5 Eli Lilly Recent Development
12.5 Sanofi
12.5.1 Sanofi Company Details
12.5.2 Company Description and Business Overview
12.5.3 Acquired Orphan Blood Diseases Therapeutics Introduction
12.5.4 Sanofi Revenue in Acquired Orphan Blood Diseases Therapeutics Business (2014-2019)
12.5.5 Sanofi Recent Development
12.6 GlaxoSmithKline
12.6.1 GlaxoSmithKline Company Details
12.6.2 Company Description and Business Overview
12.6.3 Acquired Orphan Blood Diseases Therapeutics Introduction
12.6.4 GlaxoSmithKline Revenue in Acquired Orphan Blood Diseases Therapeutics Business (2014-2019)
12.6.5 GlaxoSmithKline Recent Development
12.7 Cyclacel Pharmaceuticals
12.7.1 Cyclacel Pharmaceuticals Company Details
12.7.2 Company Description and Business Overview
12.7.3 Acquired Orphan Blood Diseases Therapeutics Introduction
12.7.4 Cyclacel Pharmaceuticals Revenue in Acquired Orphan Blood Diseases Therapeutics Business (2014-2019)
12.7.5 Cyclacel Pharmaceuticals Recent Development
12.8 Onconova Therapeutics
12.8.1 Onconova Therapeutics Company Details
12.8.2 Company Description and Business Overview
12.8.3 Acquired Orphan Blood Diseases Therapeutics Introduction
12.8.4 Onconova Therapeutics Revenue in Acquired Orphan Blood Diseases Therapeutics Business (2014-2019)
12.8.5 Onconova Therapeutics Recent Development
12.9 Incyte Corporation
12.9.1 Incyte Corporation Company Details
12.9.2 Company Description and Business Overview
12.9.3 Acquired Orphan Blood Diseases Therapeutics Introduction
12.9.4 Incyte Corporation Revenue in Acquired Orphan Blood Diseases Therapeutics Business (2014-2019)
12.9.5 Incyte Corporation Recent Development
12.10 CTI BioPharma
12.10.1 CTI BioPharma Company Details
12.10.2 Company Description and Business Overview
12.10.3 Acquired Orphan Blood Diseases Therapeutics Introduction
12.10.4 CTI BioPharma Revenue in Acquired Orphan Blood Diseases Therapeutics Business (2014-2019)
12.10.5 CTI BioPharma Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Acquired Orphan Blood Diseases Therapeutics Key Market Segments
Table Key Players Acquired Orphan Blood Diseases Therapeutics Covered
Table Global Acquired Orphan Blood Diseases Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Acquired Orphan Blood Diseases Therapeutics Market Size Market Share by Type 2014-2025
Figure Medication Figures
Table Key Players of Medication
Figure Bone Marrow Transplant Figures
Table Key Players of Bone Marrow Transplant
Figure Blood Transfusion Figures
Table Key Players of Blood Transfusion
Figure Iron Therapy Figures
Table Key Players of Iron Therapy
Table Global Acquired Orphan Blood Diseases Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Others Case Studies
Figure Acquired Orphan Blood Diseases Therapeutics Report Years Considered
Table Global Acquired Orphan Blood Diseases Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Acquired Orphan Blood Diseases Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Acquired Orphan Blood Diseases Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Acquired Orphan Blood Diseases Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Acquired Orphan Blood Diseases Therapeutics Market Share by Regions 2014-2019
Figure Global Acquired Orphan Blood Diseases Therapeutics Market Share by Regions 2014-2019
Figure Global Acquired Orphan Blood Diseases Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Acquired Orphan Blood Diseases Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Acquired Orphan Blood Diseases Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Acquired Orphan Blood Diseases Therapeutics Market Share by Manufacturers in 2018
Table Global Acquired Orphan Blood Diseases Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Acquired Orphan Blood Diseases Therapeutics Product/Solution/Service
Table Date of Enter into Acquired Orphan Blood Diseases Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Acquired Orphan Blood Diseases Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Acquired Orphan Blood Diseases Therapeutics Market Size Share by Type (2014-2019)
Figure Global Acquired Orphan Blood Diseases Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Acquired Orphan Blood Diseases Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Acquired Orphan Blood Diseases Therapeutics Market Size Share by Application (2014-2019)
Figure Global Acquired Orphan Blood Diseases Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Acquired Orphan Blood Diseases Therapeutics Revenue Market Share by Application in 2018
Figure United States Acquired Orphan Blood Diseases Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Acquired Orphan Blood Diseases Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Acquired Orphan Blood Diseases Therapeutics Market Share (2018-2019)
Table United States Acquired Orphan Blood Diseases Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Acquired Orphan Blood Diseases Therapeutics Market Share by Type (2014-2019)
Table United States Acquired Orphan Blood Diseases Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Acquired Orphan Blood Diseases Therapeutics Market Share by Application (2014-2019)
Figure Europe Acquired Orphan Blood Diseases Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Acquired Orphan Blood Diseases Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Acquired Orphan Blood Diseases Therapeutics Market Share (2018-2019)
Table Europe Acquired Orphan Blood Diseases Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Acquired Orphan Blood Diseases Therapeutics Market Share by Type (2014-2019)
Table Europe Acquired Orphan Blood Diseases Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Acquired Orphan Blood Diseases Therapeutics Market Share by Application (2014-2019)
Figure China Acquired Orphan Blood Diseases Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Acquired Orphan Blood Diseases Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Acquired Orphan Blood Diseases Therapeutics Market Share (2018-2019)
Table China Acquired Orphan Blood Diseases Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Acquired Orphan Blood Diseases Therapeutics Market Share by Type (2014-2019)
Table China Acquired Orphan Blood Diseases Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Acquired Orphan Blood Diseases Therapeutics Market Share by Application (2014-2019)
Figure Japan Acquired Orphan Blood Diseases Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Acquired Orphan Blood Diseases Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Acquired Orphan Blood Diseases Therapeutics Market Share (2018-2019)
Table Japan Acquired Orphan Blood Diseases Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Acquired Orphan Blood Diseases Therapeutics Market Share by Type (2014-2019)
Table Japan Acquired Orphan Blood Diseases Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Acquired Orphan Blood Diseases Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Acquired Orphan Blood Diseases Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Acquired Orphan Blood Diseases Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Acquired Orphan Blood Diseases Therapeutics Market Share (2018-2019)
Table Southeast Asia Acquired Orphan Blood Diseases Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Acquired Orphan Blood Diseases Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Acquired Orphan Blood Diseases Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Acquired Orphan Blood Diseases Therapeutics Market Share by Application (2014-2019)
Figure India Acquired Orphan Blood Diseases Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Acquired Orphan Blood Diseases Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Acquired Orphan Blood Diseases Therapeutics Market Share (2018-2019)
Table India Acquired Orphan Blood Diseases Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Acquired Orphan Blood Diseases Therapeutics Market Share by Type (2014-2019)
Table India Acquired Orphan Blood Diseases Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Acquired Orphan Blood Diseases Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Acquired Orphan Blood Diseases Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Acquired Orphan Blood Diseases Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Acquired Orphan Blood Diseases Therapeutics Market Share (2018-2019)
Table Central & South America Acquired Orphan Blood Diseases Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Acquired Orphan Blood Diseases Therapeutics Market Share by Type (2014-2019)
Table Central & South America Acquired Orphan Blood Diseases Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Acquired Orphan Blood Diseases Therapeutics Market Share by Application (2014-2019)
Table Alexion Pharmaceuticals Company Details
Table Alexion Pharmaceuticals Revenue in Acquired Orphan Blood Diseases Therapeutics Business (2014-2019) (Million US$)
Figure Alexion Pharmaceuticals Revenue Growth Rate in Acquired Orphan Blood Diseases Therapeutics Business (2014-2019)
Table Alexion Pharmaceuticals Recent Development
Table Amgen Company Details
Table Amgen Revenue in Acquired Orphan Blood Diseases Therapeutics Business (2014-2019)(Million US$)
Figure Amgen Revenue Growth Rate in Acquired Orphan Blood Diseases Therapeutics Business (2014-2019)
Table Amgen Recent Development
Table Celgene Corporation Company Details
Table Celgene Corporation Revenue in Acquired Orphan Blood Diseases Therapeutics Business (2014-2019)(Million US$)
Figure Celgene Corporation Revenue Growth Rate in Acquired Orphan Blood Diseases Therapeutics Business (2014-2019)
Table Celgene Corporation Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Acquired Orphan Blood Diseases Therapeutics Business (2014-2019)(Million US$)
Figure Eli Lilly Revenue Growth Rate in Acquired Orphan Blood Diseases Therapeutics Business (2014-2019)
Table Eli Lilly Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Acquired Orphan Blood Diseases Therapeutics Business (2014-2019)(Million US$)
Figure Sanofi Revenue Growth Rate in Acquired Orphan Blood Diseases Therapeutics Business (2014-2019)
Table Sanofi Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Acquired Orphan Blood Diseases Therapeutics Business (2014-2019)(Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Acquired Orphan Blood Diseases Therapeutics Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Cyclacel Pharmaceuticals Company Details
Table Cyclacel Pharmaceuticals Revenue in Acquired Orphan Blood Diseases Therapeutics Business (2014-2019)(Million US$)
Figure Cyclacel Pharmaceuticals Revenue Growth Rate in Acquired Orphan Blood Diseases Therapeutics Business (2014-2019)
Table Cyclacel Pharmaceuticals Recent Development
Table Onconova Therapeutics Company Details
Table Onconova Therapeutics Revenue in Acquired Orphan Blood Diseases Therapeutics Business (2014-2019)(Million US$)
Figure Onconova Therapeutics Revenue Growth Rate in Acquired Orphan Blood Diseases Therapeutics Business (2014-2019)
Table Onconova Therapeutics Recent Development
Table Incyte Corporation Company Details
Table Incyte Corporation Revenue in Acquired Orphan Blood Diseases Therapeutics Business (2014-2019)(Million US$)
Figure Incyte Corporation Revenue Growth Rate in Acquired Orphan Blood Diseases Therapeutics Business (2014-2019)
Table Incyte Corporation Recent Development
Table CTI BioPharma Company Details
Table CTI BioPharma Revenue in Acquired Orphan Blood Diseases Therapeutics Business (2014-2019)(Million US$)
Figure CTI BioPharma Revenue Growth Rate in Acquired Orphan Blood Diseases Therapeutics Business (2014-2019)
Table CTI BioPharma Recent Development
Table Global Acquired Orphan Blood Diseases Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Acquired Orphan Blood Diseases Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Acquired Orphan Blood Diseases Therapeutics Market Size Share by Regions in 2025
Figure United States Acquired Orphan Blood Diseases Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Acquired Orphan Blood Diseases Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Acquired Orphan Blood Diseases Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Acquired Orphan Blood Diseases Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Acquired Orphan Blood Diseases Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Acquired Orphan Blood Diseases Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Acquired Orphan Blood Diseases Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Acquired Orphan Blood Diseases Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Acquired Orphan Blood Diseases Therapeutics Market Size by Product (2019-2025)
Figure Global Acquired Orphan Blood Diseases Therapeutics Market Size by Product in 2025
Table Global Acquired Orphan Blood Diseases Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Acquired Orphan Blood Diseases Therapeutics Market Size by Application (2019-2025)
Figure Global Acquired Orphan Blood Diseases Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
後天性オーファンブラッド病の世界市場：市場規模・現状・予測 Acquired orphan blood disease is a type of rare blood disorder, which occurs due to the presence of insufficient amount of red blood cells in the blood. This disease is characterized by the body?s inability to produce red blood cells. Moreover, improper functioning of bone marrow also leads to lack …- 孤立性肺疾患治療の世界市場：市場規模・現状・予測 Orphan illnesses are those which are not generally looked into, those where particular medicines are not accessible, and those which may just be of restricted enthusiasm to researchers and specialists.Orphan lung diseases are exemplified by the purported disregarded infectious diseases, which are en…
- 幹細胞臍帯血の世界市場：市場規模・現状・予測 Umbilical cord blood (UCB) stem cells have gained much significance in medical science owing to their ability to transform into any type of human cells. UCB refers to the blood that remains in the attached umbilical cord and placenta after childbirth. Stem cells that UCB contains are considered uniq…
- 世界の鎌状赤血球貧血治療法市場：動向・競争分析 Sickle cell anemia is an inherited form of anemia — a condition in which there aren't enough healthy red blood cells to carry adequate oxygen throughout your body.In 2018, the global Sickle Cell Anemia Therapeutics market size was xx million US$ and is forecast to xx million US in 2025, growing at a…
- 鎌状赤血球貧血治療法の世界市場：市場規模・現状・予測 Sickle cell disease (SCD) is a chronic, inherited blood disorder that impacts hemoglobin, a protein found in red blood cells (RBCs) that carries oxygen throughout the body. The disease is caused by a genetic mutation in the beta-chain of hemoglobin, which results in the formation of abnormal hemoglo…